PHARMACEUTICAL PREPARATIONS REDUCTION

Brand Owner (click to sort) Address Description
ALADOTE PledPharma AB Grev Turegatan 11 C SE-114 46 Stockholm Sweden Pharmaceutical preparations for reduction of liver failure;
ALADOTE Egetis Therapeutics AB Klara Norra Kyrkogata 26 Stockholm 11122 Sweden Pharmaceutical preparations for the reduction of liver failure;ALA DOTE;
C.A.T SON YOU NA 113-701, 270 Sinbanpo-ro,Seocho-gu, Seoul 113-701 Republic of Korea Pharmaceutical preparations for reduction of local body and face fat ; pharmaceutical preparations for skin care; dietetic food, namely, powders and tablets, adapted for medical use; sanitary preparations for medical purposes; nutritional supplements;
CORTONE PBM Pharmaceuticals, Inc. 200 Garrett Street, Suite O Charlottesville VA 22902 Pharmaceutical preparations for the reduction of inflammation;
CYTOFAB Protherics Inc. 5214 Maryland Way Suite 405 Brentwood TN 37027 PHARMACEUTICAL PREPARATIONS FOR THE REDUCTION OR ELIMINATION OF CYTOKINES;
CYTOTAB Therapeutic Antibodies Inc. 1500 West 21st Avenue South, Suite 310 Nashville TN 37212 pharmaceutical preparations for the reduction or elimination of cytokines;
TARAXAL ALIZYME THERAPEUTICS LIMITED Granta ParkGreat Abington Cambridge CB1 6GS United Kingdom PHARMACEUTICAL PREPARATIONS FOR THE REDUCTION OF SIDE EFFECTS ASOCIATED WITH THE TREATMENT OF CANCER;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.